Last Price
80.48
Today's Change
-7.88 (8.91%)
Day's Change
80.06 - 88.93
Trading Volume
2,261,494
Exchange: NASDAQ Global Market NASDAQ Global Market
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Dr. Waleed H. Hassanein M.D. Dr. Waleed H. Hassanein M.D.
Full Time Employees: 584 584
IPO Date: 2019-05-02 2019-05-02
CIK: 0001756262 0001756262
ISIN: US89377M1099 US89377M1099
CUSIP: 89377M109 89377M109
Beta: 2.07 2.07
Last Dividend: 0.00 0.00
Dcf Diff: 84.04 84.04
Dcf: -0.09 -0.09
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for extracorporeal perfusion and preservation of donor hearts; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.